TMCnet News
Research and Markets: Global HIV Infection Drug Market & Pipeline InsightDUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/bjt4bz/global_hiv) has announced the addition of the "Global HIV Infection Drug Market & Pipeline Insight" report to their offering. The rate of HIV infection and the number of deaths due to AIDS has been on a declining note at a positive rate across the globe. It has been estimated that the death rate reduced from 2.3 million in 2005 to 1.5 in 2013, with the rates for children being even much lower. A major cause for such drastic changes in the infection rates has been the improved access to antiretroviral drugs and theray in recent years. The access to these drugs and therapy has improved significantly, particularly in many developing countries where these drugs and treatments were previously not available at all. At present these solutions have been made accessible and affordable also. However, a major trend observed in this market has been that although the HIV infection rates are falling, the number of new patients being affected by the virus is increasing. With all the conscious efforts undertaken by all the related organizations and stakeholders, it is expected that by 2015, significant investments would be recorded in this field with the WHO setting an aim to treat close to 15 million HIV patients. Key Topics Covered: 1. Global HIV Infection Drug Market Overview 2. Global HIV Infection Drug Market Dynamics 3. FDA Regulatory Framework for Development of HIV Vaccine 4. EMA (News - Alert) Regulatory Framework for Development of Medicinal Products For Treatment Of HIV Infection 5. Global HIV Infection Drug Clinical Pipeline by Phase, Company & Country 6. Marketed HIV Drug Clinical Profile by Company & Country 7. Suspended & Discontinued HIV Drugs in Clinical Pipeline by Phase, Company & Country 8. Competitive Landscape For more information visit http://www.researchandmarkets.com/research/bjt4bz/global_hiv |
